keyword
MENU ▼
Read by QxMD icon Read
search

scleroderma guidelines

keyword
https://www.readbyqxmd.com/read/27833730/general-diseases-influence-on-peri-implantitis-development-a-systematic-review
#1
REVIEW
Zygimantas Guobis, Ingrida Pacauskiene, Inesa Astramskaite
OBJECTIVES: To systematically review the influence of systemic diseases or medications used in their treatment on the dental implant therapy success. MATERIAL AND METHODS: The search strategy was implemented on the National Library of Medicine database (MEDLINE) (Ovid) and EMBASE electronic databases between January 2006 and January 2016. Human studies with available English articles analysing the relationship between dental implant therapy success and systemic diseases, such as diabetes mellitus, AIDS/HIV, rheumatoid arthritis, osteoporosis, Crohn's disease, cardiovascular diseases, scleroderma, Sjögren's syndrome, lichen planus, ectodermal dysplasia, post-transplantation status, were included in present review according to the PRISMA guidelines...
July 2016: Journal of Oral & Maxillofacial Research
https://www.readbyqxmd.com/read/27749244/uk-scleroderma-study-group-ukssg-guidelines-on-the-diagnosis-and-management-of-scleroderma-renal-crisis
#2
Bernadette M Lynch, Edward P Stern, Voon Ong, Mark Harber, Aine Burns, Christopher P Denton
The UK Scleroderma Study Group developed guidelines on the diagnosis and management of scleroderma renal crisis (SRC) based on best available evidence and clinical experience. SRC is characterised by the acute onset of severe hypertension and acute kidney injury. Current strategies to reduce the associated morbidity and mortality include identifying at risk patients to aid early diagnosis. ACE inhibitor therapy should be lifelong in all patients, regardless of whether they require renal replacement therapy...
September 2016: Clinical and Experimental Rheumatology
https://www.readbyqxmd.com/read/27514197/-rheumatology-progress-in-diagnosis-and-treatments-topics-iv-collagen-diseases-except-for-rheumatoid-arthritis-and-hot-topics-3-systemic-sclerosis-scleroderma
#3
REVIEW
Hidekata Yasuoka
No abstract text is available yet for this article.
October 10, 2014: Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
https://www.readbyqxmd.com/read/27390939/left-ventricular-diastolic-dysfunction-and-increased-left-ventricular-mass-index-related-to-pulmonary-hypertension-in-patients-with-systemic-autoimmune-disease-without-pericardial-effusion
#4
Atsushi Sugiura, Nobusada Funabashi, Koya Ozawa, Yoshio Kobayashi
PURPOSE: We investigated the relationship of left ventricular (LV) diastolic dysfunction and LV mass index (LVMI) against pulmonary hypertension (PH) in systemic autoimmune disease (SAD). METHODS: A total of 84 SAD patients (68 females; 53±17years; systemic lupus erythematosus, 27%; scleroderma, 17%; vasculitis, 16%; mixed connective tissue disease, 13% and polymyositis/dermatomyositis complex, 10%) without significant pericardial effusion (PE) on TTE (Vivid E9, GE) were analyzed...
October 1, 2016: International Journal of Cardiology
https://www.readbyqxmd.com/read/26868300/emergency-situations-in-rheumatology-with-a-focus-on-systemic-autoimmune-diseases
#5
Jiri Vymetal, Martina Skacelova, Andrea Smrzova, Anna Klicova, Marketa Schubertova, Pavel Horak, Josef Zadrazil
BACKGROUND AND AIM: Rheumatic diseases are commonly considered chronic conditions. However, acute manifestations can be very severe and represent a diagnostic problem. Examples are systemic lupus erythematosus with acute flare, glomerulonephritis, CNS disorders and catastrophic antiphospholipid syndrome, scleroderma with interstitial lung disease, pulmonary hypertension and renal crisis and polyangiitis with alveolar haemorhage and acute respiratory failure. This aim of this paper is to overview emergency situations which can be encountered in the care of patients with autoimmune systemic diseases and vasculitides...
March 2016: Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
https://www.readbyqxmd.com/read/26819124/german-guidelines-for-the-diagnosis-and-therapy-of-localized-scleroderma
#6
Alexander Kreuter, Thomas Krieg, Margitta Worm, Jörg Wenzel, Pia Moinzadeh, Annegret Kuhn, Elisabeth Aberer, Karin Scharffetter-Kochanek, Gerd Horneff, Emma Reil, Tobias Weberschock, Nicolas Hunzelmann
Localized scleroderma designates a heterogeneous group of sclerotic skin disorders. Depending on the subtype, severity, and site affected, adjacent structures such as adipose tissue, muscles, joints, and bones may be involved. This is an update of the existing German AWMF (Association of the Scientific Medical Societies in Germany) guidelines (classification: S2k). These guidelines provide an overview of the definition, epidemiology, classification, pathogenesis, laboratory workup, histopathology, clinical scoring systems, as well as imaging and device-based workup of localized scleroderma...
February 2016: Journal der Deutschen Dermatologischen Gesellschaft, Journal of the German Society of Dermatology: JDDG
https://www.readbyqxmd.com/read/26718896/factors-associated-with-development-of-gastrointestinal-problems-in-patients-with-scleroderma-a-systematic-review
#7
REVIEW
Brian Younho Hong, Raymond Giang, Lawrence Mbuagbaw, Maggie Larche, Lehana Thabane
BACKGROUND: Up to 90% of people with scleroderma have gastrointestinal (GI) problems such as constipation, bloating, diarrhea, and malabsorption. These problems significantly impair quality of life. Our objective was to determine the risk factors for gastrointestinal issues in people with scleroderma. METHODS: We conducted a systematic review of observational studies that report GI problems in patients with scleroderma along with the associated risk factors. We were interested in any GI problem and any risk factor as long as the study included patients diagnosed with scleroderma according to the 1980 or 2013 American College of Rheumatology guideline...
2015: Systematic Reviews
https://www.readbyqxmd.com/read/26684622/digital-ulcers-in-scleroderma-patients-a-retrospective-observational-study
#8
A De Cata, M Inglese, F Molinaro, S De Cosmo, R Rubino, M Bernal, G Mazzoccoli
BACKGROUND: The guidelines for digital ulcers (DUs) management in systemic sclerosis (SSc) indicate the use of iloprost to induce wound healing and bosentan to prevent the onset of new DU. The aim of our study was to evaluate whether the combination treatment may surmount the effect of the single drug. METHODS: We analyzed data regarding 34 patients with SSc and at least one active DU persisting despite 6 months of iloprost therapy, and treated for other 6 months with a combination therapy, i...
June 2016: International Journal of Immunopathology and Pharmacology
https://www.readbyqxmd.com/read/26359329/serum-prealbumin-is-an-independent-predictor-of-mortality-in-systemic-sclerosis-outpatients
#9
MULTICENTER STUDY
Veronica Codullo, Emanuele Cereda, Catherine Klersy, Ilaria Cavazzana, Claudia Alpini, Chiara Bonardi, Annalisa Turri, Franco Franceschini, Riccardo Caccialanza, Carlomaurizio Montecucco, Roberto Caporali
OBJECTIVE: Serum prealbumin is a recognized marker of malnutrition, but its role in the prognosis of patients with SSc has not yet been investigated. The aim of the present multicentre prospective study was to investigate the association between prealbumin and mortality, independent of clinical features, in a cohort of SSc outpatients. METHODS: Patients were followed up according to standard clinical guidelines with visits at least every 6 months. Data collected included records of skin and internal organ involvement, survival and causes of death...
February 2016: Rheumatology
https://www.readbyqxmd.com/read/26339894/content-of-non-pharmacological-care-for-systemic-sclerosis-and-educational-needs-of-european-health-professionals-a-eushnet-survey
#10
Linda M Willems, Anthony C Redmond, Tanja A Stamm, Carina Boström, Saskia Decuman, Ann Tyrrell Kennedy, Jadranka Brozd, Sanja Roškar, Vanessa Smith, Theodora P M Vliet Vlieland, Cornelia H M van den Ende
OBJECTIVES: To describe the non-pharmacological care in systemic sclerosis (SSc) provided by European health professionals (HPs) including referrals, treatment targets, interventions, and educational needs. METHODS: In this observational study, European HPs working in SSc care were invited to complete an online survey through announcements by EUSTAR (European League Against Rheumatism (EULAR) Scleroderma Trials and Research) and FESCA (Federation of European Scleroderma Associations), the EULAR HPs' newsletter, websites of national patient and HP associations, and by personal invitation...
July 2015: Clinical and Experimental Rheumatology
https://www.readbyqxmd.com/read/26320140/application-of-the-detect-algorithm-for-detection-of-risk-of-pulmonary-arterial-hypertension-in-systemic-sclerosis-data-from-a-czech-tertiary-centre
#11
Tomas Soukup, Radek Pudil, Katerina Kubinova, Lucie Hromadkova, Jaroslav Dusek, Marian Tosovsky, Petr Bradna, Zbynek Hrncir, Jan Bures
OBJECTIVE: The early, simple and reliable detection of pulmonary arterial hypertension (PAH) in SSc (DETECT) study described a new algorithm for early detection of PAH in patients with SSc. The aim of this retrospective, single-centre, cross-sectional study was to apply a modified DETECT calculator in patients with SSc in the East Bohemian region, Czech Republic, to assess the risk of PAH and to compare these results with PAH screening based on the European Society of Cardiology/European Respiratory Society (ESC/ERS) 2009 guidelines...
January 2016: Rheumatology
https://www.readbyqxmd.com/read/26139334/update-on-systemic-sclerosis
#12
REVIEW
Courtney J McCray, Maureen D Mayes
Systemic sclerosis (SSc) is a rare autoimmune disease characterized by autoantibody production, small-vessel vasculopathy, and skin and other organ fibrosis. The disease is clinically heterogeneous with most patients having some degree of skin sclerosis with varying organ system involvement. Early disease can be difficult to diagnose, especially with minimal skin sclerosis and absence of anti-nuclear antibody (ANA) positivity; however, studies have demonstrated early diagnosis is important as early treatment could potentially lead to better outcomes...
May 2015: Current Allergy and Asthma Reports
https://www.readbyqxmd.com/read/26121522/a-comparison-between-general-rheumatologists-and-scleroderma-experts-with-respect-to-following-systemic-sclerosis-guidelines
#13
COMPARATIVE STUDY
Jason Reed, Janet Pope
OBJECTIVES: To determine if there are differences between expert and non-expert rheumatologists in systemic sclerosis (SSc) management. METHODS: Information relating to demographics, complications, investigations, and treatment of SSc patients was obtained from an online survey to members of the Canadian Rheumatology Association (CRA), and selected chart audits. Results were compared to data from a SSc database ('experts', Canadian Scleroderma Research Group--CSRG)...
July 2015: Clinical and Experimental Rheumatology
https://www.readbyqxmd.com/read/26115973/-systemic-sclerosis-current-classification-and-diagnosis-of-organ-involvement
#14
REVIEW
O D Persa, P Moinzadeh, N Hunzelmann
Systemic sclerosis (SSc) is a rare, chronic inflammatory autoimmune disease with unknown etiology, which leads to deposition of collagen and extracellular matrix proteins in the skin and affected internal organs. The diagnosis of SSc is based on clinical, serological, and paraclinical examinations. In 2013 new criteria for the classification of systemic sclerosis, which also take early forms of SSc into consideration, were developed. A complete clinical and paraclinical examination is important for the oligosymptomatic early stages and the subsequent disease course of SSc in order to diagnose and timely treat a developing organ involvement...
August 2015: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete
https://www.readbyqxmd.com/read/25881068/progressive-hemifacial-atrophy-a-review
#15
REVIEW
Stanislav N Tolkachjov, Nirav G Patel, Megha M Tollefson
BACKGROUND: Progressive Hemifacial Atrophy (PHA) is an acquired, typically unilateral, facial distortion with unknown etiology. The true incidence of this disorder has not been reported, but it is often regarded as a subtype of localized scleroderma. Historically, a debate existed whether PHA is a form of linear scleroderma, called morphea en coup de sabre (ECDS), or whether these conditions are inherently different processes or appear on a spectrum (; Adv Exp Med Biol 455:101-4, 1999; J Eur Acad Dermatol Venereol 19:403-4, 2005)...
2015: Orphanet Journal of Rare Diseases
https://www.readbyqxmd.com/read/25874345/new-acr-eular-guidelines-for-systemic-sclerosis-classification
#16
Sindhu R Johnson
The American College of Rheumatology and European League Against Rheumatism classification criteria for systemic sclerosis are a significant advancement in the field. This article describes the innovative, rigorous, criteria development strategy that was used. The new criteria build upon previous criteria by incorporating important elements (proximal scleroderma, sclerodactyly, digital pits, pulmonary fibrosis, Raynaud's phenomenon, and scleroderma specific autoantibodies). The new criteria add emphasis to the vasculopathic manifestations, and include the early manifestation of puffy fingers...
May 2015: Current Rheumatology Reports
https://www.readbyqxmd.com/read/25805510/-common-german-language-nomenclature-for-systemic-sclerosis
#17
M Aringer, U Müller-Ladner, H Burkhardt, J H W Distler, O Distler, W B Graninger, C Günther, N Hunzelmann, H Kiener, M Sticherling, C Sunderkötter, U A Walker, G Riemekasten
Large data bases and the projects arising from them have led to a much improved understanding of systemic sclerosis over the last decade. Serology has developed further so that more autoantibodies are available for routine testing. Capillary microscopy has become standard and relevant progress has also been made in therapy. Many diagnostic terms found in medical documentation do not adequately reflect this progress. The nomenclature is inconsistent and, therefore, confusing. The international classification of diseases (ICD) nomenclature is, from our point of view, also in need of improvement...
March 2015: Zeitschrift Für Rheumatologie
https://www.readbyqxmd.com/read/25735576/prospects-for-improving-outcomes-in-systemic-sclerosis-related-pulmonary-hypertension
#18
REVIEW
V Thakkar, M Nikpour, W M Stevens, S M Proudman
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with systemic sclerosis (SSc). Approximately one in 10 will develop PAH during their lifetime. These patients have a worse prognosis than those with PAH due to other causes. The most common clinical feature of SSc-PAH in the early stages is non-specific exercise intolerance that can be erroneously attributed to other manifestations of SSc. Screening provides an opportunity for early identification of SSc-PAH and prompt initiation of therapies with the potential to improve quality of life and survival...
March 2015: Internal Medicine Journal
https://www.readbyqxmd.com/read/25596924/a-comparison-of-the-predictive-accuracy-of-three-screening-models-for-pulmonary-arterial-hypertension-in-systemic-sclerosis
#19
MULTICENTER STUDY
Yanjie Hao, Vivek Thakkar, Wendy Stevens, Kathleen Morrisroe, David Prior, Candice Rabusa, Peter Youssef, Eli Gabbay, Janet Roddy, Jennifer Walker, Jane Zochling, Joanne Sahhar, Peter Nash, Susan Lester, Maureen Rischmueller, Susanna M Proudman, Mandana Nikpour
INTRODUCTION: There is evidence that early screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improves outcomes. We compared the predictive accuracy of two recently published screening algorithms (DETECT 2013 and Australian Scleroderma Interest Group (ASIG) 2012) for SSc-associated PAH (SSc-PAH) with the commonly used European Society of Cardiology/European Respiratory Society (ESC/ERS 2009) guidelines. METHODS: We included 73 consecutive SSc patients with suspected PAH undergoing right heart catheterization (RHC)...
2015: Arthritis Research & Therapy
https://www.readbyqxmd.com/read/25449678/a-prisma-driven-systematic-review-for-predictive-risk-factors-of-digital-ulcers-in-systemic-sclerosis-patients
#20
REVIEW
I Silva, J Almeida, C Vasconcelos
Vasculopathy has a major role in the pathogenesis and tissue injury in systemic sclerosis (SSc). Raynaud's phenomenon (RP) is frequently the first clinical manifestation of SSc preceding by years other clinical manifestations. RP in SSc patients is frequent, often very severe and long lasting. The repeated bouts of RP lead to prolonged digital ischemia that may progress to digital ulceration or in extreme to critical digital ischemia with gangrene. Digital ulcers (DU) are a true burden for all patients. They are very painful, with a long and slow healing course, have high risk of infection and are extremely disabling...
February 2015: Autoimmunity Reviews
keyword
keyword
119698
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"